The General Behavior Inventory<\/a> (GBI), originally developed by Richard A. Depue<\/a> and colleagues in 1981, represents one of the most rigorously evaluated psychometric instruments designed to identify the presence, frequency, and severity of affective symptomatology across the bipolar spectrum<\/a> and unipolar depressive disorders<\/a>. Developed within a behavioural high-risk paradigm, the GBI was engineered to identify individuals exhibiting subclinical or syndromal manifestations of cyclothymia<\/a>, bipolar II disorder<\/a>, bipolar I disorder<\/a>, and major depressive disorder. In its classical adult self-report format, the instrument comprises 73 items scored on a 4-point Likert-type scale<\/a> ranging from 0 (“never or hardly ever”) to 3 (“very often or almost constantly”), evaluating chronic and episodic behavioural manifestations over the preceding year. The inventory is divided into two primary overarching subscales: a 45-item Depression scale and a 28-item Hypomanic\/Biphasic scale, the latter capturing hypomanic activation as well as rapid cyclic mood alternation. Items can be scored using continuous dimensional summation or a categorical, dichotomous “case-scoring” threshold model (where responses of 2 or 3 are scored as 1, indicating clinically salient symptom manifestation). Extensive psychometric validation has confirmed excellent internal consistency, with Cronbach’s alpha<\/a> values consistently exceeding .90 to .95 across diverse clinical and nonclinical samples, robust 15-week test-retest reliability ($r = .73$<\/span>), and superior discriminant validity<\/a> in differentiating bipolar spectrum conditions from unipolar depression, attention-deficit\/hyperactivity disorder<\/a> (ADHD), and disruptive behaviour disorders. Subsequent developments have introduced validated parent-report versions (P-GBI) and empirically abbreviated screeners, such as the 14-item 7 Up 7 Down Inventory, demonstrating the tool’s enduring clinical and empirical utility.<\/p>\n General Behavior Inventory, GBI, bipolar disorder, cyclothymia, hypomania, unipolar depression, mood disorders, behavioral activation system, psychometrics, psychiatric assessment, affective lability, high-risk paradigm<\/p>\n The General Behavior Inventory was formulated and psychometrically established by a distinguished team of clinical psychologists and behavioural neuroscientists led by Richard A. Depue, Ph.D.<\/strong>, Professor Emeritus of Human Development and Psychology at Cornell University. Depue’s pioneering research integrated neurobiology, neurochemistry (specifically central dopaminergic functioning), and behavioural observation to map the biological vulnerability underpinnings of affective illness.<\/p>\n The original seminal 1981 validation was co-authored by:<\/p>\n Subsequent psychometric expansions, clinical adaptations, child and adolescent parent-report formats, and short-form derivations have been led extensively by Eric A. Youngstrom, Ph.D.<\/strong>, Professor of Psychology and Neuroscience and Psychiatry at the University of North Carolina at Chapel Hill<\/a>, in collaboration with prominent child and adolescent psychiatrists such as Robert L. Findling, M.D., M.B.A.<\/strong> (Stony Brook University \/ Johns Hopkins University) and Joseph R. Calabrese, M.D.<\/strong> (Case Western Reserve University).<\/p>\n The primary purpose of the General Behavior Inventory is the operationalised, dimensional identification of individuals exhibiting behavioural manifestations characteristic of the bipolar spectrum, cyclothymia, and unipolar affective illness. Developed in an era when psychiatric taxonomy relied almost exclusively on cross-sectional categorical criteria that frequently obscured sub-syndromal and temperamental variations, the GBI was engineered within a “behavioural high-risk paradigm.” The conceptual rationale posited that genetic vulnerability to bipolar disorder is expressed continuously in the population through sub-affective, cyclothymic, and chronic dysregulatory traits. The GBI was designed to capture this lifelong phenotypic vulnerability prior to, during, and between full-blown acute syndromal episodes.<\/p>\n In clinical practice, the GBI serves several pivotal functions:<\/p>\n The GBI operationalises affective disorder pathology through a multi-dimensional framework that distinguishes between purely unipolar depressive manifestations and the dynamic, oscillating manifestations characteristic of bipolar spectrum liability. Affective illness is conceptualised not as static states of mood disturbance, but as regulatory impairments across behavioural activation, motoric energy, cognitive cadence, and vegetative biological rhythms.<\/p>\n The Depression subscale evaluates both core psychological and somatic-vegetative features of sustained low mood. Crucially, the GBI items assess not merely transitory sadness, but prolonged periods where energy, self-esteem, and psychomotor speed are chronically or episodically dampened without obvious environmental triggers. The construct comprises:<\/p>\n Representative Conceptual Item:<\/em> “Have you become sad, depressed, or irritable for several days or more without really understanding why?”<\/p>\n The hypomanic construct in the GBI is bifurcated into pure behavioural activation\/euphoria and rapid mood oscillation (biphasic\/lability). Depue and colleagues recognised that hypomanic states in non-clinical or community settings rarely present solely as classical, uninterrupted euphoria; rather, they are characterized by irritability, hyper-reactivity, racing ideation, and sudden shifts into exhaustion or dysphoria.<\/p>\n Representative Conceptual Item:<\/em> “Has your mood or energy shifted rapidly back and forth from happy to sad or high to low?”<\/p>\n The General Behavior Inventory is rooted in the neurobehavioral theory of affective disorders formulated by Richard A. Depue, which integrates Reinforcement Sensitivity Theory<\/a>, central neurochemistry, and Kraepelinian<\/a> continuous psychopathology models.<\/p>\n At the core of Depue’s theoretical model is the Behavioral Facilitation System (BFS)<\/strong>, conceptually equivalent to Jeffrey Gray’s Behavioral Approach System (BAS)<\/a>. The BFS is a neurobehavioral motivational system mediated primarily by ascending mesolimbic and mesocortical dopaminergic pathways<\/a> originating in the ventral tegmental area and projecting to the nucleus accumbens, amygdala, and prefrontal cortex. The BFS is responsible for:<\/p>\n Depue and colleagues postulated that the core biological vulnerability to bipolar spectrum disorders consists of a genetically determined hypersensitivity, hyper-reactivity, and homeostatic instability of the BFS<\/strong>. In individuals predisposed to bipolar disorder, the BFS lacks regulatory equilibrium:<\/p>\n The GBI rejects strict Kraepelinian dichotomies that separate clinical disease from normal personality. Instead, drawing from Hagop Akiskal’s conceptualisation of the bipolar spectrum, the GBI assumes that affective temperament, sub-clinical cyclothymia, bipolar II disorder, and bipolar I disorder exist on a unified neurobiological continuum. The GBI was designed explicitly to measure the behavioural expressions of this underlying dimension, demonstrating that high GBI scorers exhibit the same neuroendocrine, electrophysiological, and familial aggregation markers as diagnosed bipolar probands.<\/p>\n The GBI has been subjected to exhaustive empirical evaluation across community, clinical, collegiate, and paediatric samples over more than four decades, yielding robust evidence for its construct, criterion, convergent, and discriminant validity.<\/p>\n In initial validation studies conducted across nonclinical collegiate cohorts and clinical psychiatric outpatients (Depue et al., 1981), individuals scoring above empirical thresholds on the GBI demonstrated substantial concordance with independent structured diagnostic interviews, including the Research Diagnostic Criteria (RDC) and subsequent DSM criteria. Convergent validity analyses demonstrate strong, statistically significant correlations between GBI Depression subscale scores and validated depressive inventories such as the Beck Depression Inventory<\/a> (BDI; $r = .65$<\/span> to $.82$<\/span>) and the Center for Epidemiologic Studies Depression Scale (CES-D). The Hypomanic\/Biphasic subscale correlates strongly with measures of BAS sensitivity, affective intensity, and hypomanic personality traits (e.g., the Hypomanic Personality Scale, $r = .60$<\/span> to $.75$<\/span>).<\/p>\n A primary psychometric strength of the GBI is its ability to differentiate clinically overlapping conditions:<\/p>\n Longitudinal prospective investigations within the Longitudinal Investigation of Bipolar Spectrum (LIBS) project (Alloy, Abramson, Depue, et al.) confirmed that high scores on the GBI Hypomanic\/Biphasic scale in non-clinical young adults prospectively predicted an elevated rate of first-onset major affective episodes, conversion to bipolar II disorder, and increased frequency of hospitalisations over multi-year follow-ups, establishing the instrument’s prognostic predictive validity.<\/p>\n While early exploratory work by Chmielewski et al. (1995) noted raw mean score differences across racial and ethnic groups (e.g., Caucasian participants reporting slightly lower symptom endorsement than minority cohorts), subsequent rigorous multi-group confirmatory factor analyses by Pendergast et al. (2015) in large Black and White young adult samples established structural and metric measurement invariance<\/em>. This confirms that the underlying latent constructs of depression and hypomanic lability are measured equivalently across racial groups, allowing unbiased comparative and clinical assessment.<\/p>\n The GBI displays consistently high indices of classical internal consistency and temporal test-retest stability across diverse study populations.<\/p>\n Across nonclinical young adults, psychiatric adult outpatients, and caregiver cohorts, the internal consistency of the GBI scales is consistently within the excellent range:<\/p>\n Because the GBI was engineered to capture chronic vulnerability traits and longitudinal behavioural patterns rather than brief, transient state fluctuations, its temporal stability is substantial:<\/p>\n Given the high reliability coefficients ($\u0007lpha > .93$<\/span>), the Standard Error of Measurement (SEM) for both the Depression and Hypomanic scales is relatively small in relation to their scale lengths. For dimensional Likert sum scoring, the SEM for the Depression scale is approximately 4.5 to 5.2 points, while for the Hypomanic scale it is approximately 3.1 to 3.8 points. When applying the dichotomous case-scoring algorithm, the SEM is further constrained, providing narrow confidence intervals around individual patient diagnostic cutoffs.<\/p>\n The internal dimensionality of the GBI has been examined through both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA), spanning adult self-report, parent-report, and brief clinical screener formats.<\/p>\n In the foundational work of Depue et al. (1981, 1987), factor analyses of the 73 items demonstrated a robust two-factor overarching structure:<\/p>\n Modern structural modeling studies (Pendergast et al., 2014, 2015) using robust weighted least squares estimators (WLSMV) on categorical item responses have tested competing structural models:<\/p>\n Item-level factor loadings on designated scales are exceptionally robust, with the majority of items demonstrating standardised factor loadings ($lambda$<\/span>) between .50 and .85<\/strong>. Cross-loadings between the unipolar depression items and pure hypomanic activation items are negligible ($< .20$<\/span>), confirming structural divergence. This clean factor structure enabled Youngstrom, Murray, Johnson, and Findling (2016) to utilise factor analytic and Item Response Theory (IRT<\/a>) parameters to extract the 14 highest-performing items, creating the 7 Up 7 Down Inventory<\/strong> (7 items measuring mania\/activation, 7 items measuring depression), which maintains the core factorial structure of the parent 73-item instrument with minimal information loss.<\/p>\n The structural, administrative, and operational parameters of the General Behavior Inventory are outlined below:<\/p>\n The General Behavior Inventory was first published in 1981 by Richard A. Depue and colleagues in the Journal of Abnormal Psychology<\/em> (American Psychological Association). Unlike many commercial proprietary psychometric inventories (e.g., MMPI-3, PAI), the original General Behavior Inventory, its parent-report adaptation (P-GBI), and the short-form 7 Up 7 Down variant have been made broadly accessible by their authors for non-profit academic research, scientific inquiry, and educational clinical training.<\/p>\n The inventory is available for open academic use without commercial royalty fees. Validated English copies, scoring templates, and translations into multiple languages (including Spanish, Dutch, and French) are maintained and distributed through academic repositories, notably through the Center for Excellence in Community Mental Health at the University of North Carolina at Chapel Hill<\/a> under the curation of Dr. Eric A. Youngstrom. While researchers and practitioners are free to download and implement the scale for scientific and clinical screening purposes, formal commercial publication, commercial electronic redistribution, or inclusion in monetised proprietary testing platforms requires written authorisation and licensing agreements from the copyright holders and original authors.<\/p>\n Chmielewski, P. M., Fernandes, L. O., Yee, C. M., & Miller, G. A. (1995). Ethnicity and gender in scales of psychosis proneness and mood disorders. Journal of Abnormal Psychology<\/em>, 104(3), 464–470. https:\/\/doi.org\/10.1037\/0021-843x.104.3.464<\/a><\/p>\n Danielson, C. K., Youngstrom, E. A., Findling, R. L., & Calabrese, J. R. (2003). Discriminative validity of the General Behavior Inventory using youth report. Journal of Abnormal Child Psychology<\/em>, 31(1), 29–39. https:\/\/doi.org\/10.1023\/A:1021717231272<\/a><\/p>\n Depue, R. A., & Klein, D. N. (1988). Identification of unipolar and bipolar affective conditions in nonclinical and clinical populations by the General Behavior Inventory. In D. L. Dunner, E. S. Gershon, & J. E. Barrett (Eds.), Relatives at risk for mental disorders<\/em> (pp. 179–202). Raven Press.<\/p>\n Depue, R. A., Krauss, S., & Spoont, M. R. (1987). A two-dimensional threshold model of seasonal bipolar affective disorder. In D. Magnusson & A. Ohman (Eds.), Psychopathology: An interactional perspective<\/em> (pp. 95–123). Academic Press.<\/p>\n Depue, R. A., Slater, J. F., Wolfstetter-Kausch, H., Klein, D. N., Goplerud, E., & Farr, D. A. (1981). A behavioral paradigm for identifying persons at risk for bipolar depressive disorder: A conceptual framework and five validation studies. Journal of Abnormal Psychology<\/em>, 90(5), 381–437. https:\/\/doi.org\/10.1037\/0021-843X.90.5.381<\/a><\/p>\n Pendergast, L. L., Youngstrom, E. A., Brown, C., Jensen, D., Abramson, L. Y., & Alloy, L. B. (2015). Structural invariance of General Behavior Inventory (GBI) scores in Black and White young adults. Psychological Assessment<\/em>, 27(1), 21–30. https:\/\/doi.org\/10.1037\/pas0000020<\/a><\/p>\n Pendergast, L. L., Youngstrom, E. A., Merkitch, K. G., Moore, K. A., Black, C. L., Abramson, L. Y., & Alloy, L. B. (2014). Differentiating bipolar disorder from unipolar depression and ADHD: The utility of the General Behavior Inventory. Psychological Assessment<\/em>, 26(1), 195–206. https:\/\/doi.org\/10.1037\/a0035138<\/a><\/p>\n Youngstrom, E. A., Findling, R. L., Danielson, C. K., & Calabrese, J. R. (2001). Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory. Psychological Assessment<\/em>, 13(2), 267–276. https:\/\/doi.org\/10.1037\/1040-3590.13.2.267<\/a><\/p>\n Youngstrom, E. A., Genzlinger, J. E., Egerton, G. A., & Van Meter, A. R. (2015). Multivariate meta-analysis of the discriminative validity of caregiver, youth, and teacher rating scales for pediatric bipolar disorder: Mother knows best about mania. Archives of Scientific Psychology<\/em>, 3(1), 112–137. https:\/\/doi.org\/10.1037\/arc0000024<\/a><\/p>\n Youngstrom, E. A., Murray, G., Johnson, S. L., & Findling, R. L. (2016). The 7 Up 7 Down Inventory: A 14-item measure of manic and depressive tendencies carved from the General Behavior Inventory. Psychological Assessment<\/em>, 25(4), 1377–1383. https:\/\/doi.org\/10.1037\/a0033975<\/a><\/p>\n Youngstrom, E. A., Zhao, J., Mankoski, R., Forbes, R. A., Marcus, R. M., Carson, W., & Findling, R. L. (2013). Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder. Journal of Child and Adolescent Psychopharmacology<\/em>, 23(2), 72–79. https:\/\/doi.org\/10.1089\/cap.2012.0024<\/a><\/p>\n2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
\n
5. Psychological Construct<\/h2>\n
1. Unipolar \/ Bipolar Depressive Dimension (45 Items)<\/h3>\n
\n
2. Hypomanic \/ Biphasic Dimension (28 Items)<\/h3>\n
\n
6. Theoretical Framework<\/h2>\n
The Behavioral Facilitation System (BFS)<\/h3>\n
\n
Neurobehavioral Model of Bipolar Vulnerability<\/h3>\n
\n
The Continuous Spectrum Paradigm<\/h3>\n
7. Validity<\/h2>\n
Construct and Convergent Validity<\/h3>\n
Discriminant Validity and Clinical Specificity<\/h3>\n
\n
Predictive and Longitudinal Validity<\/h3>\n
Cross-Cultural and Demographic Invariance<\/h3>\n
8. Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Stability<\/h3>\n
\n
Standard Error of Measurement (SEM)<\/h3>\n
9. Factor Analysis<\/h2>\n
Original Exploratory Factor Structure<\/h3>\n
\n
Confirmatory Factor Analysis (CFA) and Bifactor Models<\/h3>\n
\n
Item Loadings and Abbreviated Derivatives<\/h3>\n
10. Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
0<\/code> = Never or hardly ever<\/li>\n1<\/code> = Sometimes<\/li>\n2<\/code> = Often<\/li>\n3<\/code> = Very often or almost constantly<\/li>\n<\/ul>\n<\/li>\n\n
0 to 135<\/code>; Hypomanic\/Biphasic scale range: 0 to 84<\/code>. Higher cumulative scores indicate greater symptom frequency and severity.<\/li>\n0<\/code> or 1<\/code> are scored as 0<\/code> (absent\/subclinical), while responses of 2<\/code> or 3<\/code> are scored as 1<\/code> (clinically significant endorsement). Subscale items are then summed:\n\n
0 to 45<\/code>.<\/li>\n0 to 28<\/code>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n\n
11. Permissions & Fee and Test Year<\/h2>\n
12. References<\/h2>\n
13. Items of the Scale<\/h2>\n